Back to search

Article

Effectiveness of Pfizer-BioNTech Vaccine Against COVID-19 Associated Hospitalizations among Lebanese Adults ≥75 years- Lebanon, April-May 2021

2022-01-24

Abstract excerpt

<h4>Introduction</h4> In Lebanon, the nationwide vaccination against COVID-19 was launched in February-2021 using Pfizer-BioNTech vaccine and prioritizing elderly, persons with comorbidities and healthcare workers. Our study aims to estimate the post-introduction vaccine effectiveness (VE) of Pfizer-BioNTech in preventing COVID-19 hospitalization among ≥75 years in Lebanon. <h4>Methods</h4> A case-control study de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
09b2b144-832d-5733-8694-eb66db480c04
DOI
10.1101/2022.01.19.22269514
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of Pfizer-BioNTech Vaccine Against COVID-19 Associated Hospitalizations among Lebanese Adults ≥75 years- Lebanon, April-May 2021DOI 10.1101/2022.01.19.22269514
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022Semantic proximity
Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity
Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity
Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity
Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity
Effectiveness of COVID-19 Vaccines Against Hospitalization in Latin America During Three Pandemic Waves, 2021-2022: A Test-Negative Case-Control DesignSemantic proximity
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesSemantic proximity
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity
Comparative effectiveness of mRNA-1273 versus protein-based NVX-CoV2705 vaccination on COVID-19-related outcomes among US insured adults during 2024–2025: a retrospective matched cohort studySemantic proximity
Primary Series COVID-19 Vaccine Effectiveness Among Health Care Workers in Albania, February–December 2021Semantic proximity
COVID-19 Vaccinations, Infections and Outcomes among 784 People Living with HIVSemantic proximity
Select a neighboring publication to make it the new centre.